Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

GRCEGRCE
7 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in GRACE THERAPEUTICS INC

CITADEL ADVISORS LLC holds 349,740 shares of GRCE (GRACE THERAPEUTICS INC), worth $793,910 as of 2026-Q2. The position was increased (+254.2% shares). GRCE represents 0.0% of CITADEL ADVISORS LLC's portfolio.

Current Value

$793,910

Current Shares

349,740

Total Value Change

+$703,750

Total Shares Change

+326,076

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
349,740
+254.2%
$793,9100.0%$2.27
40
2026-Q1
Increased
98,742
+133.4%
$457,1760.0%$3.93
39
2025-Q4
Increased
42,297
+55.1%
$147,6170.0%$3.37
21
2025-Q3
Decreased
27,265
-20.7%
$80,9770.0%$2.97
0
2025-Q2
Decreased
34,382
-10.5%
$102,1150.0%$2.97
0
2025-Q1
Increased
38,403
+62.3%
$87,5590.0%$2.32
21
2024-Q4
New
23,664
-
$90,1600.0%$3.85
33

Other major holders of GRCE: Cerity Partners LLC, BANK OF AMERICA CORP /DE/, VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used